We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ACS Global Inc (CE) | USOTC:AMCY | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 0.00 | 01:00:00 |
Mr. Anthony Dudzinski, CEO, stated, "We are excited to complete this name change as the final step in our transaction with R & A Productions, Inc. ACS Global will continue to explore opportunities globally to secure and expand its position within the stem cell and regenerative medicine industry."
About ACS Global, Inc.: ACS Global, Inc. is the controlling shareholder of American CryoStem Corporation, and develops new technologies internally and through strategic relationships in the rapidly developing regenerative medicine and stem cell industry.
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the Company is detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
For More Information, contact: Investor Relations American CryoStem Corporation 188 East Bergen Place, Suite 204 Red Bank, NJ 07701 Phone:732-747-1007 Fax: 732-747-7782 www.americancryostem.com
1 Year ACS Global (CE) Chart |
1 Month ACS Global (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions